Patents by Inventor Johnson Yiu-Lam LAU

Johnson Yiu-Lam LAU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis and treatment of MERS-related renal disease
    Patent number: 10782303
    Abstract: Methods for treating, diagnosing, and providing prognostic information for kidney disease related to MERS-CoV infection are described. Transcription and translation products (for example, mRNA or peptides) of FGF2, Smad7, and/or sequences upstream of FGF2 are useful as markers that indicate kidney disease and/or provide prognostic information related to the course of kidney disease related to MERS-CoV infection. Such kidney disease can be treated and/or mitigated by reducing the availability of FGF2, Smad7, and/or a sequence upstream from FGF2 by reducing and/or regulating transcription and by sequestering related peptides using a large molecule binding partner, such as an antibody. Sequences for useful siRNAs and antisense oligonucleotides are provided.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: September 22, 2020
    Assignee: EMV Mers (HK) Limited
    Inventors: Man-Lung Yeung, Jasper Fuk-Woo Chan, Johnson Yiu-Lam Lau, Kwok Yung Yuen
  • DIAGNOSIS AND TREATMENT OF MERS-RELATED RENAL DISEASE
    Publication number: 20180149659
    Abstract: Methods for treating, diagnosing, and providing prognostic information for kidney disease related to MERS-CoV infection are described. Transcription and translation products (for example, mRNA or peptides) of FGF2, Smad7, and/or sequences upstream of FGF2 are useful as markers that indicate kidney disease and/or provide prognostic information related to the course of kidney disease related to MERS-CoV infection. Such kidney disease can be treated and/or mitigated by reducing the availability of FGF2, Smad7, and/or a sequence upstream from FGF2 by reducing and/or regulating transcription and by sequestering related peptides using a large molecule binding partner, such as an antibody. Sequences for useful siRNAs and antisense oligonucleotides are provided.
    Type: Application
    Filed: June 3, 2016
    Publication date: May 31, 2018
    Inventors: Man Lung YEUNG, Jasper Fuk-Woo CHAN, Johnson Yiu-Lam LAU, Kwok-Yung YUEN